Blog
maison / Blog / Novo Long-Acting Growth Hormone Side Chain
catégories
Novo Long-Acting Growth Hormone Side Chain August 19,2026.

The Novo long-acting growth hormone side chain is a fatty acid-modified functional side chain designed for long-acting modification strategy research. This molecule combines a fatty acid structural unit with a linker module and can be used for the construction of biomacromolecule functionalization modification systems, with application value in long-acting protein and peptide modification, as well as bioconjugation-related research.


I. Basic Information

Item Content
Name Novo Long-Acting Growth Hormone Side Chain
Molecular Weight 1340

The Novo long-acting growth hormone side chain is a fatty acid-modified linker structure, composed of a fatty acid group, a linking unit, and amino acid-related structures. It can be introduced into target molecules via chemical conjugation for functionalization modification research.


II. Structural Characteristics and Mechanism of Action

1. Fatty Acid Segment – Providing a Hydrophobic Interaction Basis
This side chain contains a fatty acid structural unit that can participate in hydrophobic interactions. In protein and peptide modification systems, the fatty acid structure serves as a functionalization modification unit, providing a structural basis for long-acting molecular design research. The fatty acid side chain undergoes non-covalent reversible binding with serum albumin. Leveraging albumin's large molecular weight and low renal clearance rate, this significantly delays drug clearance and prolongs half-life.

2. Linker Unit – Modulating Spatial Structure
The linking structure within the side chain provides spatial spacing between the fatty acid module and the target molecule, helping to optimize the connection between different functional modules and offering flexibility for bioconjugation structure design.

3. Amino Acid Structural Module – Supporting Conjugation Modification
This side chain contains amino acid-related structural units that can participate in biomolecule conjugation design for constructing different types of functionalized modification systems.


III. Main Applications

1. Long-Acting Protein Drug Modification Research
The fatty acid-modified side chain can be used for structural modification studies of proteins and peptide molecules, exploring the effects of introducing fatty acid functional modules on molecular properties and behavior.

2. Growth Hormone Long-Acting Research
As a modification side chain related to long-acting growth hormone, it can be used for structural modification and long-acting design research of growth hormone-class molecules.

3. Peptide Drug Functionalization Modification
Leveraging its modular structural characteristics, this side chain can be used for chemical modification and functional expansion of peptide molecules, supporting the design and research of novel peptide drug derivatives.

4. Protein Conjugation and Drug Delivery Research
The fatty acid-modified side chain can serve as a linking unit, combining with target biomolecules for research on protein conjugation systems, drug delivery strategies, and functionalization applications of biomaterials.


IV. Related Products

Product Name CAS #
C20-diacid-Trx-γGlu-Glu-PEG3-ethylmaleimide X
4-Sulfobutanoic Acid 175476-52-5
16-(1H-Tetrazol-5-yl)hexadecanoic Acid 873874-15-8
4-(N-(16-(1H-tetrazol-5-yl)hexadecanoyl)sulfamoyl)butanoic Acid
Long-Acting Growth Hormone Side Chain
Fmoc-L-Lys-C20(OtBu)-Glu(OtBu)-AEEA 2612237-97-3
tBuO-Ara-Glu(AEEA-AEEA-OH)-OtBu 1188328-37-1
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH 2915356-76-0
Fmoc-Ile-Aib-OH 2171139-20-9
Boc-Tyr(tBu)-Aib-Glu(OtBu)-Gly-OH

droits d'auteur © XIAMEN SINOPEG BIOTECH CO., LTD. tous les droits sont réservés.

maison

des produits

nouvelles

contact